These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 995099)

  • 1. [Determination of factor VIII inhibitor in hemophiliacs].
    Mancini AF; Rosito P; Paolucci G
    Minerva Pediatr; 1976 Nov; 28(36):2181-5. PubMed ID: 995099
    [No Abstract]   [Full Text] [Related]  

  • 2. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS
    N Engl J Med; 1969 Oct; 281(16):866-73. PubMed ID: 5812255
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W; Muntean W
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative effects of the reaction between factor VIII and factor VIII inhibitors.
    McMillan CW; Elston RC
    Thromb Diath Haemorrh; 1971 Aug; 26(1):124-34. PubMed ID: 5112370
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
    Sultan Y; Brouet JC; Debre P
    N Engl J Med; 1974 Nov; 291(20):1087. PubMed ID: 4414451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anticoagulant in patients with hemophilia A.
    Uszyński L; Lopaciuk S
    Pol Med J; 1969; 8(4):862-9. PubMed ID: 4105591
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of factor VIII inhibitor development in hemophilia A patients treated with less pure plasma derived concentrates.
    de Biasi R; Rocino A; Papa ML; Salerno E; Mastrullo L; De Blasi D
    Thromb Haemost; 1994 May; 71(5):544-7. PubMed ID: 8091377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exchange transfusion in the treatment of the hemophilic child with factor VIII inhibitors].
    Benítez-Aranda H; Farfán Canto JM; Esparza-Flores MA; Bernaldez-Ríos R; Alvarez-Amaya C
    Bol Med Hosp Infant Mex; 1985 Nov; 42(11):687-91. PubMed ID: 3936511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemophilia A complicated by the presence of a circulating anticoagulant].
    Zawilska K; Owczarek L; Furmaniuk J
    Acta Haematol Pol; 1973; 4(3):265-8. PubMed ID: 4754133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Curves of factor VIII activity in the plasma of hemophiliacs after injection of 500 units of lyophilized factor VIII].
    Zanichelli M; Carelli Cde R; Coelho E; Salem MZ
    AMB Rev Assoc Med Bras; 1982; 28(11-12):261-3. PubMed ID: 6820526
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor.
    Chuansumrit A; Isarangkura P; Krutvecho T; Hathirat P; Pintadit P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():139-43. PubMed ID: 2499649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII inhibitor in multitransfused hemophiliacs. A finding of varying therapeutic consequences].
    Ly B; Evensen SA; Stavem P
    Tidsskr Nor Laegeforen; 1977 Apr; 97(12):554-6, 8. PubMed ID: 854906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.